Annual CFO:
-$109.03M-$17.08M(-18.58%)Summary
- As of today, EWTX annual cash from operations is -$109.03 million, with the most recent change of -$17.08 million (-18.58%) on December 31, 2024.
- During the last 3 years, EWTX annual cash from operations has fallen by -$75.52 million (-225.39%).
- EWTX annual cash from operations is now -1088.83% below its all-time high of -$9.17 million, reached on December 31, 2019.
Performance
EWTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$32.58M+$5.28M(+13.95%)Summary
- As of today, EWTX quarterly cash from operations is -$32.58 million, with the most recent change of +$5.28 million (+13.95%) on June 30, 2025.
- Over the past year, EWTX quarterly cash from operations has dropped by -$6.48 million (-24.84%).
- EWTX quarterly cash from operations is now -1089.56% below its all-time high of -$2.74 million, reached on March 31, 2020.
Performance
EWTX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$124.78M-$6.48M(-5.48%)Summary
- As of today, EWTX TTM cash from operations is -$124.78 million, with the most recent change of -$6.48 million (-5.48%) on June 30, 2025.
- Over the past year, EWTX TTM cash from operations has dropped by -$21.19 million (-20.46%).
- EWTX TTM cash from operations is now -4455.64% below its all-time high of -$2.74 million, reached on March 31, 2020.
Performance
EWTX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EWTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -18.6% | -24.8% | -20.5% |
| 3Y3 Years | -225.4% | -100.6% | -168.3% |
| 5Y5 Years | -1088.8% | -717.6% | -1755.7% |
EWTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -225.4% | at low | -174.8% | +13.9% | -148.6% | at low |
| 5Y | 5-Year | -1088.8% | at low | -717.6% | +13.9% | -1755.7% | at low |
| All-Time | All-Time | -1088.8% | at low | -1089.6% | +13.9% | -4455.6% | at low |
EWTX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$32.58M(+14.0%) | -$124.78M(-5.5%) |
| Mar 2025 | - | -$37.87M(-40.5%) | -$118.30M(-8.5%) |
| Dec 2024 | -$109.03M(-18.6%) | -$26.96M(+1.5%) | -$109.03M(-0.1%) |
| Sep 2024 | - | -$27.37M(-4.9%) | -$108.90M(-5.1%) |
| Jun 2024 | - | -$26.10M(+8.7%) | -$103.58M(-6.0%) |
| Mar 2024 | - | -$28.60M(-6.6%) | -$97.72M(-6.3%) |
| Dec 2023 | -$91.95M(-74.7%) | -$26.83M(-21.6%) | -$91.95M(-19.5%) |
| Sep 2023 | - | -$22.06M(-9.0%) | -$76.97M(-15.1%) |
| Jun 2023 | - | -$20.23M(+11.4%) | -$66.88M(-6.3%) |
| Mar 2023 | - | -$22.83M(-92.5%) | -$62.89M(-19.5%) |
| Dec 2022 | -$52.63M | -$11.86M(+0.9%) | -$52.63M(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$11.96M(+26.4%) | -$50.20M(-8.0%) |
| Jun 2022 | - | -$16.25M(-29.2%) | -$46.50M(-16.2%) |
| Mar 2022 | - | -$12.57M(-33.5%) | -$40.02M(-19.4%) |
| Dec 2021 | -$33.51M(-129.0%) | -$9.42M(-14.0%) | -$33.51M(-16.6%) |
| Sep 2021 | - | -$8.26M(+15.4%) | -$28.73M(-40.4%) |
| Jun 2021 | - | -$9.77M(-61.3%) | -$20.46M(-39.4%) |
| Mar 2021 | - | -$6.06M(-30.6%) | -$14.68M(-29.2%) |
| Dec 2020 | -$14.63M(-59.6%) | -$4.64M(-16.4%) | -$11.36M(-69.0%) |
| Jun 2020 | - | -$3.98M(-45.5%) | -$6.72M(-145.5%) |
| Mar 2020 | - | -$2.74M | -$2.74M |
| Dec 2019 | -$9.17M | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Edgewise Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of EWTX is -$109.03M
What is the all-time high annual cash from operations for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual cash from operations is -$9.17M
What is Edgewise Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, EWTX annual cash from operations has changed by -$17.08M (-18.58%)
What is Edgewise Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of EWTX is -$32.58M
What is the all-time high quarterly cash from operations for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly cash from operations is -$2.74M
What is Edgewise Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, EWTX quarterly cash from operations has changed by -$6.48M (-24.84%)
What is Edgewise Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of EWTX is -$124.78M
What is the all-time high TTM cash from operations for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM cash from operations is -$2.74M
What is Edgewise Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, EWTX TTM cash from operations has changed by -$21.19M (-20.46%)